Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Orchard Therapeutics plc ORTX

Full chart Compare
Set alert

Price alert · ORTX

All alert types
16.70 +16.70

Day range unavailable

52-week range unavailable

Financial health

Altman Z-Score

-2.95 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -6.1×
FY 2016: -7.4×FY 2017: -3.6×FY 2018: -1.5×FY 2019: -7.8×FY 2020: -2.8×FY 2021: -4.5×FY 2022: -6.1×
FY 2016 5y median -4.5× FY 2022
P/S 6.8×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 171×FY 2019: 510×FY 2020: 166×FY 2021: 339×FY 2022: 6.8×
FY 2016 5y median 171× FY 2022
P/B 0.5×
FY 2016: -8.6×FY 2017: 1.6×FY 2018: 1.1×FY 2019: 4.3×FY 2020: 2.4×FY 2021: 0.8×FY 2022: 0.5×
FY 2016 5y median 1.1× FY 2022
P/FCF -0.6×
FY 2016: -9.6×FY 2017: -4.2×FY 2018: -3.5×FY 2019: -7.5×FY 2020: -3.1×FY 2021: -1.3×FY 2022: -0.6×
FY 2016 5y median -3.1× FY 2022
EV/EBITDA -0.2×
FY 2016: -7.2×FY 2017: -1.3×FY 2018: -0.1×FY 2019: -8.1×FY 2020: -2.9×FY 2021: -1.2×FY 2022: -0.2×
FY 2016 5y median -1.2× FY 2022
EV/Sales 5.3×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 9.2×FY 2019: 521×FY 2020: 167×FY 2021: 346×FY 2022: 5.3×
FY 2016 5y median 167× FY 2022
FCF Yield -174.2%
FY 2016: -10.4%FY 2017: -24.1%FY 2018: -28.6%FY 2019: -13.3%FY 2020: -32.3%FY 2021: -78.4%FY 2022: -174.2%
FY 2016 5y median -32.3% FY 2022

Profitability

Gross Margin 65.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 79.7%FY 2019: 68.0%FY 2020: 67.0%FY 2021: 53.2%FY 2022: 65.2%
FY 2016 5y median 67.0% FY 2022
Operating Margin -452.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -11321.3%FY 2019: -6879.1%FY 2020: -6049.2%FY 2021: -7539.3%FY 2022: -452.2%
FY 2016 5y median -6879.1% FY 2022
Net Margin -112.8%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -11102.8%FY 2019: -6503.1%FY 2020: -5856.6%FY 2021: -7525.7%FY 2022: -112.8%
FY 2016 5y median -6503.1% FY 2022
ROE -8.0%
FY 2016: 115.5%FY 2017: -46.0%FY 2018: -74.0%FY 2019: -54.6%FY 2020: -85.2%FY 2021: -17.3%FY 2022: -8.0%
FY 2016 5y median -54.6% FY 2022
ROIC -15.9%
FY 2016: -4103.2%FY 2017: -44.5%FY 2018: -73.9%FY 2019: -48.8%FY 2020: -64.2%FY 2021: -12.7%FY 2022: -15.9%
FY 2016 5y median -48.8% FY 2022
ROA -3.6%
FY 2016: -445.6%FY 2017: -40.8%FY 2018: -63.0%FY 2019: -40.9%FY 2020: -54.1%FY 2021: -11.3%FY 2022: -3.6%
FY 2016 5y median -40.9% FY 2022

Growth (YoY)

Revenue 1346.4%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 21.1%FY 2020: 3.3%FY 2021: -81.4%FY 2022: 1346.4%
FY 2016 FY 2022
Operating Income 13.2%
FY 2016: 0.0%FY 2017: -100.6%FY 2018: -510.3%FY 2019: 26.4%FY 2020: 9.2%FY 2021: 76.8%FY 2022: 13.2%
FY 2016 FY 2022
EPS (diluted) 79.2%
FY 2016: 0.0%FY 2017: -108.3%FY 2018: -159.5%FY 2019: 82.8%FY 2020: 12.8%FY 2021: 80.8%FY 2022: 79.2%
FY 2016 FY 2022
Free Cash Flow 35.7%
FY 2016: 0.0%FY 2017: -130.7%FY 2018: -198.3%FY 2019: -67.9%FY 2020: 18.5%FY 2021: 7.6%FY 2022: 35.7%
FY 2016 FY 2022

Financial Health

Current Ratio 2.8×
FY 2016: 1.0×FY 2017: 8.8×FY 2018: 7.4×FY 2019: 6.3×FY 2020: 4.3×FY 2021: 6.4×FY 2022: 2.8×
FY 2016 5y median 6.3× FY 2022
Quick Ratio 2.7×
FY 2016: 1.0×FY 2017: 8.8×FY 2018: 7.4×FY 2019: 6.3×FY 2020: 4.3×FY 2021: 6.4×FY 2022: 2.7×
FY 2016 5y median 6.3× FY 2022
Debt / Equity 0.6×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.2×FY 2020: 0.3×FY 2021: 0.3×FY 2022: 0.6×
FY 2016 5y median 0.3× FY 2022
Net Debt / EBITDA 0.1×
FY 2016: 0.2×FY 2017: 2.4×FY 2018: 1.4×FY 2019: -0.2×FY 2020: -0.0×FY 2021: -0.0×FY 2022: 0.1×
FY 2016 5y median -0.0× FY 2022
Interest Coverage -33.9×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -112×FY 2020: -67.4×FY 2021: -53.3×FY 2022: -33.9×
FY 2016 5y median -53.3× FY 2022

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2016 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2016 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31